Corpus Intelligence IC Memo — HCA FLORIDA NORTHSIDE HOSPITAL 2026-04-26 06:38 UTC
IC Memo — HCA FLORIDA NORTHSIDE HOSPITAL
Investment Committee Memorandum | FL | 230 beds | Grade C | EBITDA uplift $12.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HCA FLORIDA NORTHSIDE HOSPITAL

CCN 100238 | PINELLAS, FL | 230 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HCA FLORIDA NORTHSIDE HOSPITAL is a 230-bed suburban community hospital in PINELLAS, FL with $171.0M in net patient revenue and a 10.6% operating margin. The hospital serves a payer mix of 26.7% Medicare, 3.4% Medicaid, and 69.9% commercial.

Thesis: Platform Growth. Our ML models identify $12.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 10.6% to 18.0% (+736bps).

Net Revenue HCRIS$171.0M
Current EBITDA COMPUTED$18.2M
Operating Margin COMPUTED10.6%
Occupancy HCRIS51.4%
Revenue / Bed COMPUTED$744K
Net-to-Gross HCRIS8.3%
Distress Probability ML46.3%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
114
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 10.6% places it above the state median. Among 114 size-comparable peers (115-460 beds), the median margin is 3.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (115-460), prioritizing same-state peers. 114 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HCA FLORIDA NORTHSIDE HOSPITAL (Target)FL230$171.0M10.6%
MOFFITT CANCER CENTERFL218$1.91B16.0%
MAYO CLINIC FLORIDAFL304$1.09B21.6%
NICKLAUS CHILDRENS HOSPITALFL259$769.3M5.5%
SOUTH MIAMI HOSPITALFL375$688.4M11.6%
BOCA RATON REGIONAL HOSPITALFL361$609.5M-9.6%
JOHNS HOPKINS ALL CHILDRENS HOFL259$584.5M-10.3%
HOLY CROSS HOSPITALFL286$566.3M-0.7%
HCA FLORIDA KENDALL HOSPITALFL424$541.2M35.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.6M+210bp18mo
Cost to Collect4.5%2.5%$3.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.1M+122bp9mo
Clean Claim Rate88.0%96.0%$109K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.6M
Cost to Collect
$3.4M
Denial Rate Reduction
$3.4M
A/R Days Reduction
$2.1M
Clean Claim Rate
$109K
Total EBITDA Uplift$12.6M
Current EBITDA$18.2M
+ RCM Uplift+$12.6M
Pro Forma EBITDA$30.8M
Current Margin10.6%
Pro Forma Margin18.0%
WC Released (1x)$6.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$28.0M$245.9M8.78x54.4%
Base (11x exit)10.0x11.0x$28.0M$279.6M9.99x58.5%
Bull Case9.0x11.0x$25.2M$330.2M13.11x67.3%
Bull (12x exit)9.0x12.0x$25.2M$367.7M14.59x70.9%
Bear Case11.0x10.0x$30.8M$173.9M5.65x41.4%
Bear (11x exit)11.0x11.0x$30.8M$201.3M6.54x45.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 114 hospitals with 115-460 beds
  • Same-state prioritization (n=115)
  • Comp margins: P25=-4.6% / P50=3.8% / P75=16.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.